Christus Stehlin Foundation for Cancer Research
- Research works
- 75 ▼ 81% vs 2013–17
- Citations
- 3.3k 43.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 15% world 28%
Not ranked overall: Christus Stehlin Foundation for Cancer Research is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Christus Stehlin Foundation for Cancer Research specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 9.1× the share of its output that it takes of world research.
- Molecular BiologySubfield · 27.4 works9.1×
- Biochemistry, Genetics and Molecular BiologyField · 36.3 works7.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Christus Stehlin Foundation for Cancer Research?
Ranked on the composite score, Beppino C. Giovanella lead among researchers whose main affiliation is Christus Stehlin Foundation for Cancer Research.
- 1 Beppino C. Giovanella United States · #34,095 worldwide 854 citations · 33 works
Which keywords describe research at Christus Stehlin Foundation for Cancer Research?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Genomic Stability, Genetic Variants, DNA, Topoisomerases, Immunotherapy, Targeted Therapy and Clinical Trials.
- Febrile Neutropenia
- Antimicrobial Agents
- Repair
- ATM and ATR Kinases
- Antibiotic Pharmacokinetics
- Receptor
- Quinones
- Genomic Instability
- Reactive Oxygen Species
- Transcriptional Regulation
- Toxicology
- Antimicrobial Activity
- Small-Cell Lung Cancer
- Anticancer Agents
- Prognostic Factors
- Biomarkers
- Cancer
- Immunotherapy
- DNA
- Genomic Stability
- Chemotherapy
- Genetic Variants
- Topoisomerases
- Targeted Therapy
- Clinical Trials
- Metastasis
- Nuclear Receptors
- Genomic Profiles
- Pharmacology
- Cell Signaling
- Breast Cancer
- Apoptosis
- Signaling
- Cytotoxicity
- Estrogen
- DNA Damage
- Critically Ill Patients
- Medicinal Chemistry
- Tumor Microenvironment
- Drug Design
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy24▲ 44×9 topics
- Genomic Stability16▲ 226×2 topics
- Genetic Variants14▲ 88×2 topics
- DNA14▲ 598×1 topic
- Topoisomerases14▲ 598×1 topic
- Immunotherapy8▲ 17×8 topics
- Targeted Therapy7▲ 42×5 topics
- Cancer7▲ 6.4×13 topics
- Clinical Trials7▲ 14×5 topics
- Biomarkers6▲ 13×3 topics
- Metastasis6▲ 22×3 topics
- Prognostic Factors6▲ 16×3 topics
- Nuclear Receptors5▲ 38×4 topics
- Anticancer Agents5▲ 25×4 topics
- Genomic Profiles5▲ 183×1 topic
- Small-Cell Lung Cancer5▲ 183×1 topic
- Pharmacology4▲ 18×3 topics
- Antimicrobial Activity4▲ 30×2 topics
- Cell Signaling4▲ 17×3 topics
- Toxicology4▲ 27×2 topics
- Breast Cancer4▲ 19×4 topics
- Transcriptional Regulation4▲ 20×3 topics
- Apoptosis4▲ 13×4 topics
- Reactive Oxygen Species4▲ 9.5×2 topics
- Signaling3▲ 39×3 topics
- Genomic Instability3▲ 34×2 topics
- Cytotoxicity3▲ 30×1 topic
- Quinones3▲ 192×1 topic
- Estrogen3▲ 54×1 topic
- Receptor3▲ 57×1 topic
- DNA Damage3▲ 29×2 topics
- Antibiotic Pharmacokinetics3▲ 79×1 topic
- Critically Ill Patients3▲ 79×1 topic
- ATM and ATR Kinases3▲ 68×1 topic
- Medicinal Chemistry3▲ 9.2×5 topics
- Repair3▲ 68×1 topic
- Tumor Microenvironment2▲ 8.3×4 topics
- Antimicrobial Agents2▲ 150×1 topic
- Drug Design2▲ 22×2 topics
- Febrile Neutropenia2▲ 150×1 topic
Which research topics does Christus Stehlin Foundation for Cancer Research publish most on?
By volume in 2022–2025: Ovarian cancer diagnosis and treatment, Patient Satisfaction in Healthcare, Primary Care and Health Outcomes and Healthcare Policy and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 2 Patient Satisfaction in Healthcare General Health Professions 0 works
- 3 Primary Care and Health Outcomes General Health Professions 0 works
- 4 Healthcare Policy and Management Economics and Econometrics 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 7 Cancer Diagnosis and Treatment Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Christus Stehlin Foundation for Cancer Research's research output changed?
Output in 2018–2022 was 81% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Houston
- The University of Texas MD Anderson Cancer Center
- Baylor College of Medicine
- University of Houston
- Rice University
- The University of Texas Health Science Center at Houston
- Johnson Space Center
- Texas Children's Hospital
- Houston Methodist
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.